Overview

Open, Randomized Crossover Study on PK, PD, Biopotency, and Bioavailability of Insulin Capsules in Healthy Chinese Males

Status:
NOT_YET_RECRUITING

Trial end date:
2025-06-01

Target enrollment:

Participant gender:

Summary

Pharmacokinetics and pharmacodynamics study of 2 formulations (human insulin enteric coated capsules 32mg vs. human insulin injection 5IU) Relative biopotency and bioavailability of human insulin enteric coated capsules 32mg vs. human insulin injection 5IU

Phase:

PHASE1

Details

Lead Sponsor:

Shanghai Jiao Tong University School of Medicine

Treatments:

Insulin